Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Feb;152(2):296-301.
doi: 10.1111/j.1365-2133.2004.06270.x.

Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis

Affiliations

Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis

P J Coenraads et al. Br J Dermatol. 2005 Feb.

Abstract

Background: A standardized instrument is needed to rate the overall severity of chronic hand dermatitis (CHD), in particular during clinical trials.

Objectives: To design and validate a photographic guide.

Methods: Initially, five experts were asked to grade 50 photographs of CHD, first individually, then as a consensus-building group, in order to select the photographs included in the guide. Then, a validation session with 11 different dermatologists evaluating 28 patients was conducted to assess the interrater reliability and test-retest reproducibility of the assessment of disease severity, relying on the photographic guide, on two consecutive days. Patient order was randomized, and only diseased hands were visible to prevent any bias in evaluation.

Results: The experts reached a consensus for development of a photographic guide composed of five severity levels and four photographs per severity level. Results of the validation session showed a high level of interrater reliability and test-retest reproducibility.

Conclusions: The photographic guide is a reliable tool for assessing the morphological severity of hand dermatitis, and can be used as part of a comprehensive evaluation of disease in international multicentre clinical trials.

PubMed Disclaimer

Comment in

Publication types